Navigation Links
Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results
Date:9/30/2010

n (150,407) (1,301,337) Taxes payable (5,028,760) 11,081,110 Net cash provided by operating activities 20,255,834 62,924,266 CASH FLOWS FROM INVESTING ACTIVITIES: Acquisition of Hongrui -- (8,584,900) Proceeds from sale of investments 531,750 407,005 Purchase of equipment (76,993) (156,702) Prepayments made for purchase of equipment (110,251) -- Purchase of intangible assets (16,979,106) -- Cash proceeds from sale of equipment -- 15,615 Net cash used in investing activities (16,634,600) (8,318,982) CASH FLOWS FROM FINANCING ACTIVITIES: Change in restricted cash (3,754,752) 538,815 Proceeds from notes payable 14,843,004 13,896,990 Principal payments on notes payable (11,088,252) (12,439,315) Borrowings on short term bank loans 2,200,050 2,197,500 Principal payments on short term bank loans (2,200,050) (2,783,500) Net cash provided (used) in financing activities -- 1,410,490 EFFECTS OF EXCHANGE RATE CHANGE IN CASH 629,384 154,545 NET INCREASE IN CASH 4,250,618 56,170,319 CASH, beginning of the period 104,366,117 48,195,798 CASH, end of the period $108,616,735 $104,366,117 SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Cash paid for interest $142,523 $2,255,809 Cash paid for taxes $14,900,838 $6,167,810 Non-cash investing and financing activities: Common stock issued to acquire Hongrui $-- 2,597,132 JIANGBO PHARMACEUTICALS, INC. AND SUBSIDIARIES (FORMERLY GENESIS PHARMACEUTICALS ENTERPRISES, INC.) RECONCILIATION OF NON-GAAP NET INCOME (Unaudited) For the Three Months For the Twelve Months Ended Ended June 30, June 30, 2010 2009 2010 2009 Net Income $7,186,273 $11,491,718 $29,850,355 $28,880,264 Loss from discontinued operations 43,023 88,116 243,792 1,781,946 Unrealized loss (gain) on investments 119,814 (1,026,097) (150,525) 229,425 Loss (gain) in fair value of derivative liabilities (1,141,384) -- (14,631,455) -- Amortization of debt discount and debt issuance costs related to convertible debentures 3,543,451 1,497,392 15,624,371 4,687,144 Adjusted Net Income $9,
'/>"/>
SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
2. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
3. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
4. Jiangbo Pharmaceuticals Announces the Appointment of New Chief Executive Officer
5. Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market
6. Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
7. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
8. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
9. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
10. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
11. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... FRANKFURT , Deutschland, 4. März 2015 ... führender Anbieter von medizinischen Bildmanagementlösungen für Unternehmen, ... Ernennung von Randolph Sternberg zum Director of ... Director of Operations weiter aus. ... Randolph Sternberg ist für den ...
(Date:3/4/2015)... , March 4, 2015  ECR Booth #317/Expo C ... is showcasing a full spectrum of X-ray imaging solutions ... reduce costs, and enable greater patient throughput for manufacturers ... systems.  These solutions are on display at the Annual ... Vienna, Austria this week.   ...
(Date:3/4/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... upcoming 27 th Annual ROTH Conference, taking place ...  Dr. Michael Berelowitz , Chairman of ... corporate overview on March 10, 2015.   ...
Breaking Medicine Technology:TeraRecon baut seine Präsenz in EMEA aus 2TeraRecon baut seine Präsenz in EMEA aus 3Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3
... 2012 Ranbaxy Laboratories Inc. (RLI), a wholly owned ... that the U.S. Food and Drug Administration (FDA) has ... acne medication isotretinoin, for the treatment of severe recalcitrant ... firm, Cipher Pharmaceuticals Inc., RLI is expected to launch ...
... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a ... it has received approval for a key patent by ... and Compositions for Oral Administration of Exenatide," covers oral ... now consists of three issued patents and 34 patents ...
Cached Medicine Technology:Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA 2Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand 2Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand 3
(Date:3/4/2015)... March 04, 2015 Alliance Healthcare Foundation ... wellness for those in need in San Diego and ... organizations through its Mission Support Grants program with awards ... organizations applied for AHF’s Mission Support Grants program. Grant ... board of trustees and program committee, as well as ...
(Date:3/4/2015)... State officials have awarded $82,500 to ... Public Health at Georgia State University, to support the ... Georgia’s Division of Family and Children Services (DFCS) as ... Center. , The 1-800-CHILDREN Helpline is a top ... referral services that promote the wellbeing of children while ...
(Date:3/4/2015)... Estates, CA (PRWEB) March 04, 2015 ... clever dialogue and lyrical music, will be performed by ... Rolling Hills Estates, CA, this March 6-22, 2015, on ... Arts Center at Peninsula High School (27118 Silver ... available one hour before the program or may be ...
(Date:3/4/2015)... March 04, 2015 The report ... client survey, marketing channels, industry development trend and ... the industry, including spices definitions, applications and industry ... market analysis are provided with a focus on ... market. A comparison between the international and Chinese ...
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is ... joined the company as Chief Technology Officer. Mr. Dvorak ... the company, including customer-centric strategies and initiatives, and promoting ... experience as a technology executive and visionary. Prior to ... FBI including oversight of enterprise data management, analytic software ...
Breaking Medicine News(10 mins):Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3
... active antiretroviral treatment (HAART) needs to be careful// ... Belgium. ,Highly active antiretroviral treatment can dramatically ... expectancy. This is especially helpful for patients with ... to have a full commitment to the antiviral ...
... neck cancer who are undergoing radiation// therapy can now ... ,Oropharyngeal candidiasis is a fungal infection in the ... also called thrush. The symptoms of the disease are ... when removed leaves a bleeding surface. This is a ...
... often had complained of a sudden increase in weight, especially ... this sudden influx of weight often results in obesity that ... rise in type 2 diabetes cases, cardiovascular diseases and other ... may be due to a drop in the estrogen levels ...
... had affected a total of 423 cases in Angola,// which ... the form of a vaccine. ,A virus causes Marburg ... Ebola hemorrhagic fever. The disease is a rare condition but ... symptoms begin with severe headaches and feeling of severe unwell. ...
... intake of vitamin B may be at less risk from ... of alcohol along with vitamin B may have even reduced ... happens when there is growth of abnormal or malignant cells ... was done by Swedish and American researchers, said that inadequate ...
... an injury to the knee. This may lead to inflammations ... identified a way to find out how much loss of ... in order to find out whether the injury may be ... considered to be a risk factor for arthritis, it was ...
Cached Medicine News:
... CELL-DYN are assayed linearity control kits that ... verify patient reportable range of three- and ... the linear performance of the analyzer. CVA ... ranges appropriate for each instrument model and ...
The technology in the LATITUDE system allows your doctor to get the same data from your device whether you are at home or in your doctor's office. This information transfer happens automatically....
... Proprietary EX.P.R.T. Release Technology essentially ... stent shortening,, Unique anatomically designed tapered ... carotid bifurcation,, 0.014 Rapid Exchange catheter ... and flexible atraumatic tip,, Radiopaque marker ...
... Para 5X is a whole blood hematology ... 60C+, 80 and 120, and the Coulter ... offers a unique white cell differential, positioning ... algorithms on the systems. The product offers ...
Medicine Products: